|
Market Closed -
Other stock markets
|
Pre-market 13:25:52 | |||
| 303.3 USD | +1.56% |
|
302.8 | -0.14% |
| 06-14 | Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto | DJ |
| 06-14 | Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer | MT |
Amgen Inc. at its Annual Meeting held on May 31, 2024 the Board appointed Dr. Klotman, a newly elected director, to serve on the Corporate Responsibility and Compliance Committee and the Governance and Nominating Committee, effective June 1, 2024.
| 1st Jan change | Capi. | |
|---|---|---|
| +5.30% | 163B | |
| +51.82% | 797B | |
| +40.58% | 628B | |
| -6.88% | 351B | |
| +16.95% | 323B | |
| +9.49% | 300B | |
| +17.04% | 244B | |
| +0.90% | 223B | |
| -6.29% | 153B | |
| -2.16% | 118B |
AMGEN INC. 
